Track the 대웅제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 대웅제약 has recorded 45 insider filings. The latest transaction was disclosed on 7 July 2026 (Other). Among the most active insiders: 국민연금공단. Every trade is openly available.
45
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
1 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Daewoong Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the Korea Exchange, XKRX.